non specific binding of antibodies in immunoassays
DESCRIPTION
Find out more about non-specific binding here: http://www.innovabiosciences.com/innova/non-specific-binding.html How to Overcome all of your Problems with Secondary Antibodies The latest Innova Biosciences webinar focuses on how to overcome the problems of using secondary antibodies. For instance, the use of secondary antibodies: • Requires a series of incubations and wash steps that are both tedious and time consuming. It is amazing how many times people state how much they hate those wash steps! • Can often be a source of non-specific staining within experiments which make data interpretation difficult or even impossible. • Multi-colour analysis often results in cross species re-activity. Secondary antibodies are generally used either because there are no directly labeled primary antibodies or to increase sensitivity. In this seminar, we will review: • How labeling of your own antibodies overcomes the need for secondary antibodies. • How easy it really is to label an antibody using Innova's 30 seconds hands-on antibody labeling kits and design your own unique research tools. • Application data such as flow cytometry and western blotting generated using directly labeled antibodies • And question the hypothesis of secondary vs. primary labeled antibodies.TRANSCRIPT
© Innova Biosciences ltd. 2012. All rights reserved © Innova Biosciences ltd. 2012. All rights reserved
Quality – Consistency - Expertise
© Innova Biosciences ltd. 2012. All rights reserved
Welcome to our third webinar
How to Overcome all your Problems with Secondary Antibodies
Dr Andy Lane
© Innova Biosciences ltd. 2012. All rights reserved
Dr Andy Lane
• Immunoassay fundamentals
• Properties of secondary antibodies
• Direct labelling of primary antibodies
Dr Lane has recently joined Innova Biosciences, where he is well positioned to utilise his antibody conjugation and flow cytometry experience in combination with Innova’s ground-breaking rapid conjugation technology.
© Innova Biosciences ltd. 2012. All rights reserved
Immunoassay fundamentals
1. Antibody specific for target antigen
DIRECT
SANDWICH
© Innova Biosciences ltd. 2012. All rights reserved
Immunoassay fundamentals
1. Antibody specific for target antigen 2. Suitable visualisation method – e.g. enzyme, fluorescent dye, nanoparticle
DIRECT
SANDWICH
© Innova Biosciences ltd. 2012. All rights reserved
Immunoassay fundamentals
In many cases these reagents are not available
DIRECT
SANDWICH
X
X
© Innova Biosciences ltd. 2012. All rights reserved
Immunoassay fundamentals
A common way to deal with this is to use a “secondary antibody” in an “indirect” assay
© Innova Biosciences ltd. 2012. All rights reserved
Properties of secondary antibodies
Anti-species immunoglobulin reagents
Single reagent may be used in many assays
Binding of multiple antibodies may increase signal
© Innova Biosciences ltd. 2012. All rights reserved
Properties of secondary antibodies
BUT……….
Level of non-specific binding in the assay is increased, especially in assays where immunoglobulins from different species are present
Multi-parameter assays are very difficult to run
Increase in sensitivity may not be realised
Assay times are increased due to the additional washes and incubation steps
© Innova Biosciences ltd. 2012. All rights reserved
Increase in non-specific binding
© Innova Biosciences ltd. 2012. All rights reserved
Increase in non-specific binding
especially in systems where immunoglobulins from different species are present
© Innova Biosciences ltd. 2012. All rights reserved
Properties of secondary antibodies
BUT……….
Level of non-specific binding in the assay is increased, especially in assays where immunoglobulins from different species are present
Multi-parameter assays are very difficult to run
Increase in sensitivity may not be realised
Assay times are increased due to the additional washes and incubation steps
© Innova Biosciences ltd. 2012. All rights reserved
Multi-parameter assays are very difficult to run
© Innova Biosciences ltd. 2012. All rights reserved
Multi-parameter assays are very difficult to run
© Innova Biosciences ltd. 2012. All rights reserved
Species cross-reactivity may be reduced by the use of antibodies that have been adsorbed against species immunoglobulin. However, as the most cross-reactive antibodies are those with highest affinity, this results in a reduction in antibody affinity and therefore performance of the antibody. Cross-reactivity may also be due to other factors such as binding to Fc receptors and general low-level non-specific interactions, which increase simply with the amount of antibody present and is not saturable.
Secondary antibody cross-reactivity
© Innova Biosciences ltd. 2012. All rights reserved
Properties of secondary antibodies
BUT……….
Level of non-specific binding in the assay is increased, especially in assays where immunoglobulins from different species are present
Multi-parameter assays are very difficult to run
Increase in sensitivity may not be realised
Assay times are increased due to the additional washes and incubation steps
© Innova Biosciences ltd. 2012. All rights reserved
All of these problems with secondary antibodies can be overcome by the use of directly conjugated primary antibodies
© Innova Biosciences ltd. 2012. All rights reserved
No non-specific binding
© Innova Biosciences ltd. 2012. All rights reserved
No non-specific binding
even in systems where immunoglobulins from different species are present
© Innova Biosciences ltd. 2012. All rights reserved
Multi-parameter assays are straightforward to run
© Innova Biosciences ltd. 2012. All rights reserved
The major problem with using directly conjugated antibodies in assays is their lack of availability, and also the difficulty of conjugating antibodies yourself by traditional methods.
© Innova Biosciences ltd. 2012. All rights reserved
Features of Lightning-Link®
• Lightning-Link ® - the world’s easiest antibody labeling kits
• Simple, one step process
• Only 30 seconds hands-on
• Reproducible
• Scalable µg to mg
• 100% recovery
Just add primary antibody !
22
© Innova Biosciences ltd. 2012. All rights reserved 23
© Innova Biosciences ltd. 2012. All rights reserved
Lightning-Link®
© Innova Biosciences ltd. 2012. All rights reserved
Lightning-Link® Rapid
Lightning-Link® is a registered trademark of Innova Biosciences DyLight® is a registered trademark of Thermo Fisher Scientific Inc. and its subsidiaries
© Innova Biosciences ltd. 2012. All rights reserved
Conjugation considerations
Antibody doesn’t meet these criteria?
You need to know some things about your antibody. Lightning-Link conjugations are really simple but you need antibody in the right format to work effectively. Commercially available antibodies come in many forms, and you may need to check with the supplier about some details.
Concentration – 1mg/ml or higher is preferred
Purity – ensure other proteins have been removed, and also make sure they haven’t been put back again afterwards!
Buffer formulation – most common formulations are suitable, but ensure that amines such as glycine are truly absent, as well as thiols such as DTT or mercaptoethanol. Tris is OK up to 20mM
Use a purification kit to purify, concentrate and/or change the buffer of your antibody
© Innova Biosciences ltd. 2012. All rights reserved 27
© Innova Biosciences ltd. 2012. All rights reserved
Using your new conjugates
• Use exactly as normal in terms of staining technique
• Titrate – possibly extensively!
• Storage – at 40C in concentrated form is always best.
• A preservative (e.g. 0.05% w/v sodium azide) may be useful, and if stored diluted a carrier protein would be advised (e.g. 1% w/v BSA)
• Some conjugates may be safely frozen, but others should not be. Never freeze RPE, APC or their tandem forms!
• Keep conjugates away from light – tandem dyes are especially sensitive
28
© Innova Biosciences ltd. 2012. All rights reserved
Directly Labeled Antibodies Indirectly Labeled Antibodies
primary antibody Goat Anti-NQO1 Goat Anti-NQO1
target quinone reductase 1 quinone reductase 1
sample lysate human kidney human kidney
primary antibody working concentration 0.00425 µg/ml 0.1 µg/ml
secondary antibody used no (direct conjugation) yes
exposure time (min) 10 10
primary antibody source Everest Biotech, Cat no: EB05370
western blot analysis
Western blotting data comparing conjugated and unconjugated antibodies (direct and indirect detection)
© Innova Biosciences ltd. 2012. All rights reserved
conjugated unconjugated
primary antibody Goat Anti-GFAP Goat Anti-GFAP
target GFAP GFAP
sample lysate mouse brain mouse brain
primary antibody working concentration 0.185 µg/ml 0.5 µg/ml
secondary antibody used no (direct conjugation) yes
exposure time (min) 3 3
primary antibody source Everest Biotech, Cat no: EB07478
western blot analysis
Western blotting data comparing conjugated and unconjugated antibodies (direct and indirect detection)
© Innova Biosciences ltd. 2012. All rights reserved © Innova Biosciences ltd. 2012. All rights reserved
Please visit our booth
ASCB annual meeting Booth 442
© Innova Biosciences ltd. 2012. All rights reserved
© Innova Biosciences ltd. 2012. All rights reserved
Contact
If you would like any more information, please contact us at [email protected]
Please keep an eye out for our future webinars and other exciting news on our website and social media channels:
www.innovabiosciences.com/innova/webinars.html
YouTube: www.youtube.com/InnovaBiosciences
© Innova Biosciences ltd. 2012. All rights reserved
Innova Biosciences Ltd.
Babraham Research Campus,
Cambridge, UK,
CB22 3AT
www.innovabiosciences.com
Lightning-Link® is a registered trademark of Innova Biosciences DyLight® is a registered trademark of Thermo Fisher Scientific Inc. and its subsidiaries